• Home
  • About ScanOats
    • Our Goals
    • Who we are
    • Organisation
  • ScanOats R&D
    • The oat genome
    • New oat varieties
    • Sustainable oat cultivation
    • Oat processing
    • Oat diet for disease prevention
    • The Pilot plant
  • News
  • Publications
  • About oat
  • Contact
  • Home
  • About ScanOats
    • Our Goals
    • Who we are
    • Organisation
  • ScanOats R&D
    • The oat genome
    • New oat varieties
    • Sustainable oat cultivation
    • Oat processing
    • Oat diet for disease prevention
    • The Pilot plant
  • News
  • Publications
  • About oat
  • Contact

Oat Polar Lipids Improve Cardiometabolic Related Markers after Breakfast and a Subsequent Standardized Lunch: A Randomized Cross over Study in Healthy Young Adults

Nov 11, 2021

nutrients-13-00988

Recent Posts

  • Emulsi Biotech’s innovative oat lipid solutions
  • Nytt centrum för livsmedelsberedskap får 60 miljoner kronor
  • ScanOats utvecklar framtidens hälsosamma havre
  • Health benefits of oat (Avena sativa) bioactives. Acute and second-meal effects of oat polar lipids and beta-glucans.
  • Havre – fördel Sverige
Our ambition with ScanOats is to take a world-leading role in the development of unique products and applications based on oat.

Visit Us

Naturvetarvägen 14
223 62 Lund, Sweden

DIRECTOR

Leif Bülow
Faculty of Engineering (LTH)

RESEARCH COORDINATOR

Inger Ahldén
Ideon Science Park
  • Hem
  • Contact
  • About oat
  • News
  • ScanOats R&D
  • Information about GDPR
Webbplatsen är producerad och drivs av Mañana Web AB